Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
- PMID: 32791005
- PMCID: PMC7667917
- DOI: 10.1164/rccm.202004-1489LE
Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
Comment in
-
Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important.Am J Respir Crit Care Med. 2020 Nov 15;202(10):1482-1483. doi: 10.1164/rccm.202006-2375LE. Am J Respir Crit Care Med. 2020. PMID: 32791006 Free PMC article. No abstract available.
Comment on
-
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69. doi: 10.1164/rccm.202003-0625ST. Am J Respir Crit Care Med. 2020. PMID: 32283960 Free PMC article.
References
-
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020 [accessed 2020 Apr 27]. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-0.... - PubMed
-
- Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, et al. European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–1331. - PubMed
-
- Dekhuijzen PNR, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817–1821. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
